We launched the COVID-19 Data Hub in March 2020 as a free resource for people and organizations to access the tracker dashboard. Our team went to work right away and developed what was to be the first of a number of tracker dashboards to help visualize the scope of the pandemic. Tableau was one of the first to recognize that data was going to play a central role in helping people see and understand what was happening. I understand that these countries may not have the same data protection laws as the country from which I provide my personal information. In particular, I consent to the transfer of my personal information to other countries, including the United States, for the purpose of hosting and processing the information as set forth in the Privacy Statement. I agree to the Privacy Statement and to the handling of my personal information. By submitting this form, you confirm that you agree to the storing and processing of your personal data by Salesforce as described in the Privacy Statement. By submitting this form, you acknowledge and agree that your personal data may be transferred to, stored, and processed on servers located outside of the People's Republic of China and that your personal data will be processed by Salesforce in accordance with the Privacy Statement. Reference Materials Toggle sub-navigationīy registering, you confirm that you agree to the processing of your personal data by Salesforce as described in the Privacy Statement.Teams and Organizations Toggle sub-navigation.**Includes the 50 states, the District of Columbia, and Puerto Rico. Healthcare facilities use Community Transmission Levels to determine infection control interventions. CDC also provides Community Transmission Levels to describe the amount of COVID-19 spread within each county. *CDC recommends use of COVID-19 Community Levels to determine the impact of COVID-19 on communities and to take action. To learn which prevention measures are recommended based on your COVID-19 Community Level, visit COVID-19 Community Level and COVID-19 Prevention. To check your COVID-19 Community Level, visit. Arizona, District of Columbia, Hawaii, New Hampshire, and Utah are the only jurisdictions to have all counties at low Community Levels. Overall, 47 out of 52 jurisdictions** had high- or medium-level counties this week. Compared with last week, the number of counties, districts, or territories in the high level decreased by 1.2%, in the medium level decreased by 3.2%, and in the low level increased by 4.3%. Publication will resume on Friday, February 24, 2023.Īs of February 9, 2023, there are 91 (2.8%) counties, districts, or territories with a high COVID-19 Community Level, 715 (22.2%) with a medium Community Level, and 2,407 (74.8%) with a low Community Level. Note to Readers: CDC will not publish the COVID Data Tracker Weekly Review on Friday, February 17, 2023. CDC’s People Who Are Immunocompromised and Steps for People with Weakened Immune Systems to Stay Safe from COVID-19 pages have more information on how to protect yourself from COVID-19. You should also consider prevention measures such as wearing a comfortable, well-fitting respirator or mask, maintaining physical distance (more than 6 feet) from others, improving indoor ventilation, and washing your hands often. If you have a weakened immune system and test positive for SARS-COV-2 or have a known exposure, talk to a doctor to get antiviral treatment as soon as possible. Everyone who is eligible should stay up to date with COVID-19 vaccines and boosters for the added protection. People who are immunocompromised might not have as strong of an immune response to COVID-19 vaccines, but staying up to date with COVID-19 vaccines will help. Vaccination is the first line of protection to prevent serious illness, hospitalization, and death from COVID-19. With this change, CDC encourages people who have weakened immune systems (or who live with someone who does) to create a COVID-19 action plan ( en español). Food and Drug Administration announced that Evusheld is not currently authorized for emergency use in the United States because it is unlikely to be active against the majority of circulating SARS-CoV-2 variants at this time. Evusheld, a pre-exposure preventative treatment, gave people with weakened immune systems extra protection against severe outcomes from COVID-19. Since the beginning of the COVID-19 pandemic almost three years ago, we have known that some people who are immunocompromised (have a weakened immune system) are more likely to get sick with COVID-19 or be sick for a longer period.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |